Medicine & Life Sciences
1 beta-methylcarbapenem
100%
8-methoxychlortetracycline
23%
AC98-6446
22%
Animal Models
24%
Anti-Bacterial Agents
80%
Bacteria
38%
Bacteriocins
48%
biapenem
25%
Carbapenem-Resistant Enterobacteriaceae
26%
Carbapenems
61%
Ceftibuten
22%
CL 331002
62%
Clostridium difficile
45%
Clostridium Infections
70%
Cricetinae
50%
Enzymes
21%
Glycopeptides
45%
Gram-Negative Bacteria
25%
imidazole
29%
Imipenem
34%
In Vitro Techniques
66%
Infections
65%
Klebsiella pneumoniae
32%
Lactams
49%
mannopeptimycin
69%
mannopeptimycin glycopeptide
46%
MEDI4893
26%
Meropenem
37%
Methicillin-Resistant Staphylococcus aureus
47%
mutacin 1140
42%
Pharmaceutical Preparations
22%
Piperacillin
41%
RFI 641
44%
saccharomicin A
22%
Serine
36%
Staphylococcal Infections
23%
Staphylococcal Pneumonia
28%
Staphylococcus
32%
Staphylococcus aureus
72%
Streptococcus pneumoniae
22%
Structure-Activity Relationship
51%
Sulbactam
21%
Tazobactam
23%
Theoretical Models
21%
Thiazepines
39%
Tigecycline
61%
TP-271
21%
Vancomycin
51%
WAY 152288
23%
Chemical Compounds
Acetal
13%
Antibacterial
26%
Antimicrobial Agent
43%
Antipseudomonal
16%
Carbapenems
20%
Carbonate
7%
Ceftibuten
8%
Cephalosporin
11%
Chlortetracycline
12%
Clavulanic Acid
7%
Crystal Structure
8%
Disaccharide
9%
Drug
7%
Electrospray Ionization
8%
Ester
13%
Glycopeptide
25%
Imidazole
18%
Imipenem
14%
Isovalerate
7%
Ketal
10%
Lantibiotic
13%
Levofloxacin
12%
Lipoteichoic Acid
7%
Meropenem
14%
Mupirocin
16%
Occurrence in Nature
7%
Parenteral
7%
Penems
45%
Pharmacological Property
10%
Piperacillin
24%
Polypeptide Antibiotic Agent
9%
Prodrug
28%
Pyrazole
9%
Reaction Intermediate
12%
Reductive Ring Cleavage
8%
Resistance
12%
Rifampicin
12%
Rifamycins
16%
Serine
10%
Stereochemistry
7%
Strain
28%
Structure-Activity Relationship
36%
Sulbactam
7%
Tandem Mass Spectrometry
7%
Tazobactam
8%
Thiazepine
19%
Triclosan
12%
Trimethylammonium
9%
Tyrosine
8%
Vancomycin
27%